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Summary
Interchromosomal associations can regulate gene expression but little is known about the
molecular basis of such associations. In response to antigen stimulation, naïve T cells can
differentiate into Th1, Th2 and Th17 cells expressing IFN-γ, IL-4 and IL-17, respectively. We
previously reported that in naïve T cells, the IFN-γ locus is associated with the Th2 cytokine
locus. Here we show that the Th2 locus additionally associates with the IL-17 locus. This
association requires a DNase I hypersensitive region (RHS6) at the Th2 locus. RHS6 and the
IL-17 promoter both bear Oct-1 binding sites. Deletion of either of these sites or Oct-1 gene
impairs the association. Oct-1 and CTCF bind their cognate sites cooperatively and CTCF-
deficiency similarly impairs the association. Finally, defects in the association lead to enhanced
IL-17 induction. Collectively, our data indicate Th17 lineage differentiation is restrained by the
Th2 locus via interchromosomal associations organized by Oct-1 and CTCF.
Introduction
Naïve CD4+ T cells can differentiate into several lineages of T helper (Th) cells, including
Th1, Th2 and Th17 cells, each defined by production of unique effector cytokines and
expression of different master transcription factors (Kanno et al., 2012; Zhu et al., 2010).
Th1 cells express interferon-γ (IFN-γ) and the transcription factor T-bet in response to
intracellular pathogens (Kanno et al., 2012; Zhu et al., 2010). Th2 cells express interleukin-4
(IL-4), IL-5 and IL-13 and the transcription factor Gata-3 and function to eliminate
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helminthic infections (Kanno et al., 2012; Zhu et al., 2010). Th17 cells express IL-17A and
IL-17F and the transcription factor RORγt and protect against extracellular bacteria and
fungi (Kanno et al., 2012; Korn et al., 2009; Zhu et al., 2010). Deregulation of T cell
differentiation and function is associated with different immunological disorders such as
autoimmune disease and allergy.
A critical feature of T helper cell differentiation into a specific lineage is the suppression of
other lineage fates and the silencing of lineage-inappropriate cytokine genes (Kanno et al.,
2012; Zhu et al., 2010). For instance, in polarized Th1 cells expressing IFN-γ efficiently, the
expression of IL-4 and IL-17 is repressed (Kanno et al., 2012). This is critically dependent
upon the transcription factor T-bet, which promotes IFN-γ production, represses IL-4
transcription, and inhibits the function of Gata-3 and RORγt, thereby antagonizing Th2 and
Th17 differentiation, respectively (Kanno et al., 2012). In Th2 cells, Gata-3 downregulates
the expression of STAT4, which mediates IL-12 signaling and Th1 differentiation (Usui et
al., 2003; Zhu et al., 2010). In addition, during Th2 differentiation, STAT5 activation, which
is critical for the maintenance of Gata-3 expression (Guo et al., 2009), can also inhibit T-bet
expression (Zhu et al., 2003; Zhu et al., 2010). However, it is still not fully understood how
T helper cells suppress other lineage fates particularly in the early time period of
differentiation before master transcription factors become expressed at high levels.
Much effort has been made to understand the cis-regulatory elements that control the
expression of lineage-determining genes (Kanno et al., 2012). Such elements, which are
often identified as conserved noncoding sequences (CNS) that exhibit DNase I
hypersensitivity, not only contain binding sites for trans-acting factors but also constitute an
integral part of gene structure and serve as centers of epigenetic changes (Kanno et al., 2012;
Lee et al., 2006). Many cis-regulatory elements have been identified in the IFN-γ, IL-4/5/13
(Th2) and IL-17 loci in T cells. For instance, CNS-1, which contains three hypersensitive
sites (HS), HSS1-HSS3, was identified in the intergenic region between the IL-4 and IL-13
loci (Takemoto et al., 1998). Two additional hypersensitive sites, HSIV and HSV are located
at the 3′ end of the IL-4 gene (Agarwal and Rao, 1998). One of the most important cis-
regulatory elements in the Th2 cytokine locus is the locus control region (LCR) (Lee et al.,
2003). An LCR is a regulatory region with dual function. As an enhancer, the LCR promotes
increased gene expression, while as an insulator it confers protection from the effects of
neighboring chromatin on a transgene (Lee et al., 2006). LCRs are likely to be closely
related to the recently described super enhancers (Whyte et al., 2013). The Th2 LCR is
located at the 3′ end of the Rad50 gene and comprises several HS sites, RHS4-7, which are
spaced over a 25kb region (Fields et al., 2004; Lee and Rao, 2004; Williams et al., 2013). In
particular, the deletion of either RHS6 or RHS7 yields a dramatic reduction in Th2 cytokine
expression, suggesting a critical role of the LCR in Th2 cytokine gene expression (Lee et al.,
2005; Williams et al., 2013).
It is generally accepted that chromosomes are compartmentalized into discrete territories
(Cremer and Cremer, 2001). Cell type-specific transcriptional regulation can be mediated in
cis at the level of chromatin and genome organization through transcription factors and
histone modifications (Hubner et al., 2012). Large scale intrachromosomal associations
between distal cis-regulatory elements and cytokine gene promoters, which may serve as a
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platform to initiate transcription by recruiting trans-acting factors in close spatial proximity,
have been reported at the Th2 cytokine locus during the differentiation of naïve T cells
toward the Th2 lineage (Spilianakis and Flavell, 2004). The LCR of the Th2 cytokine locus
plays a central role in mediating these intrachromosomal associations in Th2 cells
(Spilianakis and Flavell, 2004). We have shown previously that the Th2 LCR on
chromosome 11 associates with the IFN-γ gene on chromosome 10 at high frequencies in
naïve T cells. Following differentiation of naïve T cells into either Th1 or Th2 effectors, the
frequency of this interchromosomal association was strongly reduced in favor of
interchromosomal enhancer-promoter associations (Spilianakis et al., 2005). This
observation suggested that dynamic intra- and interchromosomal associations between
specific loci regulate transcription activation or silencing during differentiation and cellular
stimulation (Spilianakis et al., 2005). However, the underlying mechanism and the
biological meaning of these intra- and interchromosomal associations remain unknown.
Specifically, the occurrence of interchromosomal associations between other cytokine loci
and the IFN-γ or the Th2 locus has not been examined. More importantly, it also remains
unclear through which mechanisms these chromosomes associate in T cells. To date, very
few factors are known to mediate or maintain the spatial organization of chromosomes.
In the present study, we report a novel interchromosomal association between the LCR of
the Th2 cytokine locus on chromosome 11 and the IL-17 locus on chromosome 1 in naïve T
cells. We demonstrate that the frequency of this association is significantly reduced after
differentiation into either Th2 or Th17 cells and importantly that this association is mediated
by a physical interaction between Oct-1 and CTCF. Deletion of Oct-1, CTCF, or the
regulatory region of the Th2 locus resulted in loss of this association and in a concomitant
reduction of binding of each factor to the cognate sites in naïve T cells. Our results suggest
that these interchromosomal associations are coordinately regulated during the
differentiation of naïve T cells into effector T cells. In addition, we identified two trans-
acting factors that control the association. Lastly, we found that a reduction in the frequency
of interchromosomal association led to enhanced IL-17 expression during the early period of
differentiation of naïve T cells into Th17 cells. We propose that interchromosomal
associations play a crucial role in gene activation or silencing during T helper
differentiation.
Results
Interchromosomal associations between the Th2 and IL-17 loci in naïve T cells
Th17 cells produce IL-17A and IL-17F as well as IL-22 and other cytokines and
differentiate from naïve T cells through the action of TGF-β and inflammatory cytokines
(Korn et al., 2009). Given that the IFN-γ locus (on chr. 10) and the Th2 cytokine locus (on
chr. 11) associate monoallelically in naïve T cells (Spilianakis et al., 2005), we sought to
determine whether the IL-17 locus on chromosome 1 similarly undergoes interchromosomal
associations with other cytokine genes. We therefore performed three-color DNA FISH in
naïve T cells and mapped the sub-nuclear positions of the IFN-γ, IL-4/13/5 and IL-17 loci
(Figure 1A). We measured the closest distance between two loci in three-dimensions using
Volocity software (Improvision) and then examined the distributions of interchromosomal
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associations between each pair of cytokine loci normalized for the nuclear diameter.
Normalized distance values ranged between 0.1 and 0.8 in the population of naïve T cells
examined. The Th2/IL-17 association was similar to the IFN-γ/Th2 association we have
previously reported (Spilianakis et al., 2005) and somewhat closer than the IFN-γ/IL-17
association (Figures 1B and S1A). We next examined the distance between other
combinations of either active or silent control genes which are located on the same
respective chromosomes as the Th2 (e.g. Drg1 and Prkca), IL-17 (e.g. Acbd6 and Pld5) and
IFN-γ loci (e.g. Fyn and Stx11). The frequency of Th2/IL-17 interchromosomal associations
was higher than the frequency of interchromosomal associations between the control loci
throughout the entire range of distances examined (Figures 1C and S1B). Using the Fisher’s
Exact test, we determined that a cutoff normalized distance value of 0.2 detected most
robustly a difference in association between the Th2 and IL-17 loci, as compared to the
control genes (Figure S1C). A normalized distance value of 0.2 corresponds to an absolute
separation distance of 1.5μm (Figure S1D). This criterion is consistent with our prior work
(Spilianakis et al., 2005) and the literature on interchromosomal associations between the
immunoglobulin loci in B cells (Hewitt et al., 2008). Approximately 40% of naïve T cells
showed a distance equal to or less than 1.5μm between the Th2 and IL-17 loci, whereas only
about 10% of naïve T cells showed interchromosomal associations between the control
Acbd6/Drg1, Prkca/Pld5, Th2/Acbd6 and IL-17/Drg1 loci (Figure 1D). The IFN-γ/Th2 and
IFN-γ/IL-17 interchromosomal distribution profiles also showed clear differences from the
control gene distribution profiles (Figures S1E and S1F). Since the Th2/IL-17 association
occurred at higher frequencies than the IFN-γ/IL-17 association, we focused further on the
former association. In particular, we examined the fate of the Th2/IL-17 association in naïve
and in differentiated effector Th2 and Th17 cells. We found that the Th2/IL-17
interchromosomal association, which predominates in naïve T cells, was dramatically
reduced after differentiation into either Th2 or Th17 cells (Figures 1E, 1F and S1G).
RHS6 is the critical region that mediates interchromosomal associations between the Th2
and IL-17 loci in naïve T cells
To identify the regions that mediate the Th2/IL-17 interchromosomal association, we
performed chromosome conformation capture (3C) assays probing several hypersensitive
regions within the Th2 locus and several conserved regions of the IL-17 locus. We detected
reproducible 3C PCR chimeric products between either RHS6 or RHS7 of the Th2 locus and
either the promoter of IL-17A or CNS164 of the IL-17 locus, suggesting that these regions
mediate the association between the Th2 and IL-17 loci in naïve T cells (Figure 2A). When
we cloned and sequenced all the 3C products, we confirmed that these were indeed chimeric
products between the Th2 and IL-17 loci (Figure S2A and data not shown). We detected
weak 3C PCR signals between the Th2 and IL-17 loci in effector Th2 and Th17 cells and in
mouse embryonic fibroblasts (MEFs) (Figures 2B and 2C). These results suggested that
several regulatory regions mediate the association between the Th2 and IL-17 loci in naïve T
cells.
We next generated RHS6 KO mice to elucidate the role of this regulatory element in the
expression of cytokines both in cis (Williams et al., 2013) and in trans via interchromosomal
associations. We found no discernible differences in the development or in the nuclear size
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of naïve T cells isolated from WT and RHS6 KO mice (Figures S2B and S2C). Interestingly,
we found that deletion of RHS6 dramatically reduced both the association frequency
between the Th2 and IL-17 loci and the previously described association frequency between
the IFN-γ and Th2 loci in naïve T cells (Figures 2D, 2E and S2D). To establish whether the
reduction in the interchromosomal association frequency in RHS6 KO cells is T cell-
intrinsic or extrinsic, for example as a consequence of alterations in the cytokine milieu, we
performed bone marrow transplantations with a 50:50 mixture of WT (CD45.1) and RHS6
KO (CD45.2) cells into Rag-1 KO recipient mice. Two month after the transfer, we sorted
naïve T cells and performed DNA FISH. We confirmed that the frequency of
interchromosomal associations was reduced in CD45.2+ (RHS6 KO) naïve T cells compared
to CD45.1+ WT naïve T cells isolated from these chimeric mice (Figure S2E). We conclude
therefore that RHS6 is a critical region that mediates the interchromosomal association of
the Th2 locus and the IL-17 locus in naïve T cells.
Oct-1 is bound at RHS6 and at the IL-17A promoter in naïve T cells
Next we investigated which factors bind to RHS6, RHS7, the promoter of IL-17A and to
CNS164 of the IL-17 locus using the Biobase biological database and NCBI dcode.org.
Among a few candidates, we selected Oct-1, since Oct-1 binding sites in RHS6 are
evolutionarily conserved (Figure S3A) and Oct-1 is expressed in naïve T cells (data not
shown). Using ChIP, we demonstrated that Oct-1 was bound to both RHS6 and to the
promoter of IL-17A in the steady state in naïve T cells (Figure 3A). Interestingly, following
differentiation into either Th2 or Th17 cells, Oct-1 binding to those regions was reduced,
concomitant with the decrease in interchromosomal associations (Figure 3A). In contrast, we
found that Oct-1 occupancy at the control Taf12 promoter was the same before and after
differentiation of naïve T cells into effector cells (Kang et al., 2009) (Figure 3A). To directly
demonstrate that the binding of Oct-1 to RHS6 mediates interchromosomal associations
between the Th2 and IL-17 loci in naive T cells, we generated RHS6ΔOct-1 KO mice in
which the two Oct-1 binding sites in RHS6 were deleted (Figures S3B and S3C). We found
that deletion of the Oct-1 binding sites in RHS6 resulted in a significant reduction in the
frequency of interchromosomal associations between the Th2 and IL-17 loci as well as
between the IFN-γ and Th2 loci in naïve T cells (Figures 3B, 3C and S3D). In addition, we
mutated the Oct-1 binding site within the IL-17A locus and investigated how this affects the
associations. Since we carried out a site-directed mutagenesis within the construct used to
generate IL-17A-GFP reporter mice (Esplugues et al., 2011) thereby yielding mutant
reporter mice on the B6 background; and to ensure there were no background effects we
compared the Oct-1 binding site mutant mice to wild type reporter mice and to C57BL/6
mice. First, we confirmed that the binding of Oct-1 to the promoter of IL-17A was reduced
in the mutant cells (Figure S3E). Second, we found that a reduction in Oct-1 binding to the
IL-17A promoter resulted in a reduction in the frequency of the Th2/IL-17
interchromosomal association but did not affect the frequency of the IFN-γ/Th2 association
(Figures 3D, 3E and S3F). We could not find a significant difference between the
association between loci of WT IL-17A-GFP reporter mice and C57BL/6 mice, which
indicates that the insertion of GFP at the end of IL-17A gene does not affect the
interchromosomal associations (Figures 3D, 3E and S3F). We propose that Oct-1 mediates
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the interchromosomal association between the Th2 and IL-17 loci by binding to RHS6 and
to the IL-17A promoter.
The binding of CTCF to RHS7 of the Th2 locus and to CNS164 of the IL-17 locus is reduced
after differentiation of naïve T cells into Th2 or Th17 cells
Since CTCF and cohesin have been implicated in mediating long-range chromosomal
associations (Merkenschlager and Odom, 2013), and CTCF binding sites within the Th2
locus have been reported previously (Ribeiro de Almeida et al., 2009), we sought to
determine the binding profiles of these factors to the regulatory regions of the Th2 and IL-17
loci. Indeed, we confirmed by ChIP that CTCF and cohesin were bound at CBS1, CBS3,
CBS6 and CBS7 in Th2 cells as previously reported (Ribeiro de Almeida et al., 2009)
(Figure 4A). Moreover, CTCF and cohesin were bound to these four sites in naïve T cells
and in effector Th17 cells (Figure 4A). Interestingly, in naïve T cells, CTCF and cohesin
were also bound at CBS5, which is located within RHS7 but unusually for a CTCF site, this
binding was decreased upon differentiation of naïve cells into either effector Th2 or Th17
cells (Figure 4A). Next we examined the binding profile of CTCF and cohesin in the IL-17
locus and found five putative CTCF binding sites (Dr. Tae Hoon Kim, personal
communication; Figure 4B, right panel). Using ChIP, we confirmed that CTCF and cohesin
were indeed bound at the S2 and S4 sites of the IL-17 locus in naïve T cells; however upon
differentiation of naïve T cells into Th17 cells, binding of both factors was reduced at the S4
site, which is located within CNS164 (Figure 4B). Thus, we conclude that CTCF and
cohesin bind to both RHS7 in the Th2 locus and to CNS164 in the IL-17 locus in naïve T
cells. Binding of both factors to these sites was diminished upon differentiation, concomitant
with the decrease in the frequency of the interchromosomal Th2/IL-17 associations.
The binding of Oct-1 or CTCF to their cognate sites is reduced in the absence of either
CTCF or RHS6 in naïve T cells
We next sought to determine the consequence of deletion of CTCF on the occupancy of
Oct-1 within RHS6 of the Th2 locus and the IL-17A promoter. There was no significant
difference in the development of CTCF WT and CTCF KO naïve T cells or in the
expression of Oct-1 in CTCF WT and KO T cells (Figures S4A and S4B). Interestingly,
however, binding of Oct-1 to RHS6 or to the IL-17A promoter was significantly reduced in
the absence of CTCF in naïve T cells (Figure 5A). Next we checked the binding of CTCF
and cohesin at their respective sites in RHS6 WT and KO T cells and found that the binding
of both proteins to CBS5 of RHS7 in the Th2 locus was reduced in the absence of the
adjacent RHS6 site, which is 6kb upstream (Figure 5B). In addition, we confirmed that
binding of CTCF to CBS5 was also reduced by deletion of the Oct-1 binding sites in RHS6,
suggesting that the reduction in CTCF binding to CBS5 is due to the absence of Oct-1
binding at RHS6 (Figure 5C). To check the possibility that the absence of Oct-1 binding at
RHS6 caused epigenetic changes at RHS7, thereby indirectly influencing CTCF binding to
CBS5 of RHS7, we performed ChIP-qPCR for H3K4me3 and H3K27me3. We could not
detect any changes in the histone methylation pattern, and we therefore conclude that
epigenetic changes secondary to Oct-1 binding are unlikely to influence binding of CTCF to
CBS5 in the absence of Oct-1 binding at RHS6 (Figure S4C). Notably, binding of CTCF and
cohesin to the S4 site of the IL-17 locus in naïve T cells was also reduced upon deletion of
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RHS6 in the Th2 locus despite the fact that these sites are located on different chromosomes
(Figure 5D). Furthermore, we observed that binding of Oct-1 to the IL-17A promoter was
reduced in the absence of RHS6 (Figure 5E). The fact that Oct-1 and CTCF reciprocally
affect each other’s binding to their respective sites led us to consider the possibility of a
physical interaction between these two factors. To address this, we performed co-
immunoprecipitation experiments with or without sonication. We used sonication to
eliminate the possibility that Oct-1 and CTCF were bound to the same DNA fragment and
interacted in cis. Using both conditions, we observed that CTCF and Oct-1 are associated in
naïve T cells (Figure 5F). Additionally, in RHS6ΔOct-1 KO naïve T cells, binding of Oct-1
to the IL-17A promoter and binding of CTCF to S4 of CNS164 was not changed (data not
shown). This suggests other factors may be involved in Th2/IL-17 association. Oct-1 and
CTCF could be part of a larger complex of proteins that mediates the association.
The frequency of interchromosomal associations between the Th2 and the IL-17 loci is
reduced in the absence of either Oct-1 or CTCF in naïve T cells
We next examined the roles of Oct-1 and CTCF in mediating interchromosomal associations
in naïve T cells. Because knock-out of Oct-1 confers a prenatal lethal phenotype, we
performed fetal liver transplantations into Rag-1 KO mice. Naïve T cells isolated from
Rag-1 KO mice transplanted with either Oct-1 WT or Oct-1 KO fetal liver, were
developmentally indistinguishable (Figure S5A). We examined the frequency of
interchromosomal associations in naïve T cells in the presence or absence of Oct-1.
Interestingly, the Th2/IL-17 associations were greatly reduced in the absence of Oct-1
(Figures 6A, 6B and S5B). We also confirmed that the frequency of associations between
the Th2 and IL-17 loci in Oct-1 KO T cells was reduced compared to Oct-1 WT T cells by
3C assays (Figure 6C). In addition, CTCF KO T cells likewise showed a reduction in
interchromosomal associations by all parameters examined (Figures 6D, 6E, 6F and S5C).
There was no detectable difference in the association frequency between the control Drg1
and Acbd6 loci in Oct-1 WT and Oct-1 KO T cells or between CTCF WT and CTCF KO T
cells (data not shown). As we found previously that IFN-γ/Th2 associations were dependent
on RHS7 (Spilianakis et al., 2005), we examined its role in the Th2/IL-17 association. Thus,
we also found that the frequency of Th2 and IL-17 associations was likewise reduced in
RHS7 KO naïve T cells (Figure S5D). Overall, we conclude that Oct-1 and CTCF play a
role in the juxtaposition of the Th2/IL-17 loci in naïve T cells.
A reduction in the frequency of interchromosomal associations leads to increased IL-17A
expression at early time points of differentiation of naïve T cells towards the Th17 lineage
Lastly, we examined the functional role of interchromosomal associations in the expression
of IL-17A in RHS6 WT and KO T cells. Since RHS6 is a critical regulatory component of
the Th2 locus, deletion of RHS6 results in a dramatic reduction in Th2 cytokine expression
(Williams et al., 2013). Interestingly, although RHS6 is located on a different chromosome,
deletion of RHS6 resulted in increased IL-17A expression at early time points of activation
(Figure 7A), as well as in an increased frequency of IL-17A producing cells (Figure 7B).
There was no detectable difference in RORγt expression between WT and RHS6 KO cells
(Figure 7C). Since the lymphoid organ environment of RHS6 KO mice might differ from
that of WT mice as a consequence of the altered ability to produce Th2 cytokines, we sought
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to minimize such differences by allowing WT and KO cells to develop in the same
environment. We therefore performed bone marrow transplantations with mixtures of WT
(CD45.1) and RHS6 KO (CD45.2) cells into Rag-1 KO mice. Five mice were analyzed and
showed an approximately 2-fold increase in IL-17A expression in RHS6 KO cells compared
to WT cells (Figure S6A). This result suggests that the increase in IL-17A expression
observed in RHS6 KO mice is T cell intrinsic and not a consequence of an alteration in the
immune status of the mice. In similar experiments, Th17 cells isolated from either Oct-1 KO
or CTCF KO mice showed an increase in IL-17A expression compared to the WT both at
the mRNA and at the protein levels at early time points of activation (Figures S6B and S6C).
Thus, the increased IL-17A production in either Oct-1 KO or CTCF KO T cells compared to
the WT, correlated with the loss of Th2/IL-17 interchromosomal associations, although we
cannot exclude an indirect effect of Oct-1 and CTCF. However, the fact that both the
RHS6ΔOct-1 KO and the IL-17A Oct-1 binding site mutant alleles phenocopy to some
extent the Oct-1 KO interchromosomal phenotype suggests that some effects at least must be
local.
Discussion
In this study, we identified and characterized a novel interchromosomal association in T
cells between the IL-17 gene on chromosome 1 and the regulatory regions of the Th2
cytokine locus on chromosome 11 in naïve CD4 T cells. As we reported previously for the
IFN-γ/Th2 association (Spilianakis et al., 2005), the frequency of the Th2/IL-17 association
was higher in naïve T cells than in effector T cells. We identified the regions that mediate
this interchromosomal association, as hypersensitive sites within the Th2 LCR and the IL-17
promoter region and determined that these are binding sites for Oct-1 and CTCF. Deletion of
Oct-1, CTCF or the RHS6 of the Th2 locus resulted in a reduced frequency of
interchromosomal associations and in a concomitant reduction of binding of each factor to
the cognate sites in naïve T cells. Finally, we demonstrated that defects in the Th2/IL-17
association led to enhanced IL-17 expression, paralleled by an increased frequency of IL-17
producing cells early during differentiation of naïve T cells toward the Th17 lineage.
Although Oct-1 has been widely studied as a regulator of transcription in many cell types
(Herr and Cleary, 1995; Rosenfeld, 1991), its precise role is still unclear. Oct-1 is known to
have both activating (Duncliffe et al., 1997; Fletcher et al., 1987; Zhou et al., 2007) and
silencing activity (dela Paz et al., 2007; Kakizawa et al., 2001; Schwachtgen et al., 1998).
Moreover, Oct-1 has been suggested to be a regulatable stabilizer of repressed and inducible
transcriptional states (Shakya et al., 2011). Notably, Oct-1 acts at hypersensitive sites that
are distant from the promoters of target genes in several cases. For example, Oct-1 regulates
the IL-3 gene in activated T cells via a T cell-specific enhancer, which is located 14kb
upstream of the gene (Duncliffe et al., 1997). In another case, Oct-1 was found at a
macrophage-specific hypersensitive site approximately 10kb upstream of the IL-12b gene,
where it played a role in nucleosome remodeling (Zhou et al., 2007). In addition, a common
single polymorphism, which creates a binding site for Oct-1 within a hypersensitive site
found 1.5kb upstream of the IL-13 gene, was strongly associated with high IL-13 expression
and total serum IgE levels (Kiesler et al., 2009). We believe these reports correlate well with
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our hypothesis that Oct-1 does not only act as an activator or repressor, but also functions as
a global regulator, which mediates or maintains the spatial organization of chromosomes.
CTCF is well known as an insulator (Bell et al., 1999) and a central player in regulating
long-range interactions in conjunction with cohesin (Wendt et al., 2008; Hadjur et al., 2009).
Numerous reports have explored the functional cooperation between CTCF and Oct-1. For
example, in the IGF2/H19 imprinting control region (ICR), CTCF selectively binds the
unmethylated maternal allele and blocks the expression of maternal IGF2 (Merkenschlager
and Odom, 2013). Surprisingly, the Oct-1 binding site in the IGF2/H19 ICR functions as a
maintenance sequence for the unmethylated state (Hori et al., 2002). Moreover, mutations of
the Oct-1 binding sites were discovered in a patient with Beckwith-Wiedemann syndrome, a
growth disorder that results from methylation defects in the IGF2/H19 ICR (Demars et al.,
2010; Poole et al., 2012). In addition, Oct-1 binding motifs occur preferentially within
nuclear lamina associated domains, which provide structural support by anchoring
chromatin to the nuclear envelope and whose borders are demarcated by CTCF (Guelen et
al., 2008; Tang et al., 2008). We, therefore, believe that these reports are consistent with our
findings that Oct-1 and CTCF regulate the spatial arrangement of chromatin by mediating
interchromosomal associations of cytokines loci in T cells. Another Oct family member,
Oct-4 has recently been shown to interact with CTCF and to control homologous X-
chromosome pairing and counting (Donohoe et al., 2009). We speculate that Oct family
proteins act as mediators of spatial organization of chromosomes in multiple cell types in
cooperation with CTCF.
We have identified Oct-1 and CTCF as mediators of interchromosomal associations in naïve
T cells, but the dynamic aspects of this process remain to. Our analysis only captures
snapshots of gene positions at different time points of T cell differentiation and activation. It
is possible that these represent stochastic gene encounters in the interchromatin domain
(Williams et al., 2010). However, our analysis clearly demonstrates that the associations of
the Th2 and IL-17 loci occurs at much higher frequencies than that of randomly selected
genes located on same chromosomes in naïve T cells. In addition, the frequency of cytokine
gene associations are dramatically reduced in response to biologic stimuli that lead to the
differentiation of naïve T cells into effector T cells. Moreover, we demonstrated that the
frequency of cytokine interchromosomal associations is reduced by depletion of two factors,
Oct-1 and CTCF, involved in T cell differentiation. Collectively, our data suggest that the
association of the IFN-γ, IL-4/5/13 and IL-17 loci in naïve T cells is regulated phenomenon,
which has functional consequences on cytokine expression.
Interestingly, deletion of the DNase I hypersensitive site of Th2 cytokine locus (RHS6),
which mediates interchromosomal associations, led to increased expression of IL-17 despite
being located on a different chromosome. The fact that deficiency of Oct-1 or CTCF, both
impaired interchromosomal associations and led to enhanced IL-17 expression upon T cell
activation, strongly suggests that interchromosomal associations functionally affect gene
expression, although we cannot exclude the possibility of indirect effects caused by deletion
of hypersensitive sites and relevant proteins.
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Recently, OBF.1, a transcriptional coactivator of Oct-1, was reported to promote Th17
differentiation (Yosef et al., 2013). Although OBF.1 is known to be constitutively expressed
in B cells, OBF.1 expression and function is induced with phorbol esters and ionomycin in
Jurkat T cells and in primary murine thymocytes (Zwilling et al., 1997). Moreover,
posttranslational modifications, such as phosphorylation at Ser184, are required for the
inducible activation of OBF.1 (Zwilling et al., 1997). We speculate that Oct-1 may have a
dual function in T cells: it may control (1) the kinetics of IL-17 induction via
interchromosomal associations during the early period of differentiation of naïve T cells into
Th17 effectors and (2) the threshold of IL-17 induction in activated Th17 effectors in
cooperation with OBF.1. Therefore, the transcriptional role of Oct-1 in the absence (e.g. in
naïve T cells) or presence (e.g. in activated effector T cells) of OBF.1 should be separately
considered.
In conclusion, we have shown that interchromosomal associations between the Th2/IL-17
alternatively expressed cytokine genes, which predominate in naïve T cells, diminish in
frequency upon differentiation and lineage commitment. We propose that Oct-1 and CTCF,
bound to the RHS6 site of the Th2 locus and to the IL-17 promoter, mediate these trans
associations. Cooperatively these factors promote the formation of a three-dimensional
interchromosomal conformation, which governs the timing and level of cytokine gene
expression. We propose that Oct-1 and CTCF play a crucial role in the transcriptional
activation of lineage-specific cytokine genes and in the repression of alternative cell fates.
Experimental Procedures
Mice
C57BL/6 mice were purchased from Jackson Laboratories or NCI. RHS6 KO mice were
generated in our lab (Williams et al., 2013). CTCF conditional KO mice were previously
described (Ribeiro de Almeida et al., 2009). Oct-1 KO mice were provided by Dr. D. Tantin
(University of Utah, USA) and IL-17A--GFP reporter mice were generated in our lab
(Esplugues et al., 2011). All animals were maintained in accordance with Yale University
Institutional Animal Care and Use Committee.
Cell sorting and cell culture conditions
CD4+ T cells were isolated from the spleen and lymph nodes of WT and KO mice and
enriched with CD4 microbeads (Miltenyi Biotech). Naïve T cells (CD4+ CD25- NK1.1-
CD44low CD62Lhigh) were sorted by flow cytometry and activated with plate-bound anti-
CD3, anti-CD28, cytokines and neutralizing antibodies. IL-4, IL-2 and anti-IFN-γ were used
for Th2 cell differentiation and TGF-β, IL-23, IL-6, anti-IL-4 and anti-IFN-γ were used for
Th17 cell differentiation. For CTCF WT and CTCF KO T cell cultures, PMA and
ionomycin stimulation was used as described previously (Ribeiro de Almeida et al., 2009).
Three-dimensional (3-D) FISH
Three-dimensional FISH was done as described previously (Spilianakis et al., 2005). BAC
clones were purchased from Genome systems (B172 for Th2 locus) or CHORI (RPCI.
24-352N22 for IFN-γ, RP24-305203 for IL-17, RP24-368F20 for Stx11, RP24-235K8 for
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Fyn, RP24-217E8 for Drg1, RP24-371K6 for Prkca, RP23-357C20 for Pld5 and
RP23-30B13 for Acbd6). Two micrograms of BAC DNA was labeled by nick translation
(Abbott) with ChromoTide Alexa Fluor 647-12-OBEA-dCTP (Molecular Probes), Spectrum
Green (Vysis) or Spectrum Orange (Vysis), according to the manufacturer’s instructions.
The images were acquired using a Leica TCS SP5 confocal microscope. The distance
between two loci in 3-D was measured using the Volocity software (Improvision). Some
scans were scored in a blinded manner.
Chromosome Conformation Capture (3C) analysis
The 3C analysis was done as described previously (Spilianakis and Flavell, 2004;
Spilianakis et al., 2005). The precipitated 3C products were quantitated using the Quantitect
SYBR Green PCR Kit (Qiagen) in a 7500 Fast Real Time PCR System (Applied
Biosystems). The sequencing of 3C PCR products was performed in two ways. First, the 3C
products, which were obtained after 35 cycles of PCR, were isolated from agarose gels using
the Qiagen PCR gel extraction kit (Qiagen) and sequenced directly. Second, the 3C
products, which were obtained after 23 cycles of PCR, were cloned into the TA vector
(Invitrogen) and sequenced.
Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described previously (Kim et al., 2007; Lerner et al., 2003).
Antibodies were purchased from Cell Signaling for anti-CTCF (#3418), from Abcam for
anti-Rad21 (ab992) and from Santa Cruz for Oct-1 (sc-232X). The precipitated chromatin
fragments were quantitated with a Quantitect SYBR Green PCR Kit (Qiagen) in a 7500 Fast
Real Time PCR System (Applied Biosystems).
Co-immunoprecipitation (Co-IP) Assay
The cells were lysed in 50mM Tris (pH 8.0), 150mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate and 0.1% SDS, 1mM dithiothreitol (DTT) and 1x complete protease inhibitor
cocktail (Roche Diagnostics) after crosslinking with dimethyl adipimidate 2HCl (Pierce) for
90 min. The cell lysates were sonicated for 0 min or 10 min. Control IgG, anti-CTCF or
anti-Oct-1 were added and incubated at 4°C. Eluates were used for Western blotting.
Real time PCR
The expression of mRNA was measured using Taqman probes (Applied Biosystems) in a
7500 Fast Real Time PCR System (Applied Biosystems).
Adoptive transplantation
Adoptive transfer of fetal liver or bone marrow was performed as described previously
(Wang et al., 2004). Briefly, the fetal liver cells were harvested from 12.5 day embryos of
Oct-1 WT or Oct-1 KO mice. Bone marrow cells were harvested from WT and RHS6 KO
mice. Rag-1 KO recipient mice (5–8 weeks old) were sub-lethally irradiated and at least one
million fetal liver cells were retro-orbitally injected. The recipient mice were analyzed 8–10
weeks after transfer.
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Statistical analysis
An unpaired Student t-test was performed for statistical analysis for all studies using the
GraphPad Prism software. Kolmogorov-Smirnow test was performed using the Minitab 16
statistical software. Fisher’s Exact test was performed using the program R. A P value <
0.05 was considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• There is an interchromosomal association of the Th2 and IL-17 loci in naïve T
cells
• The association require DNase I hypersensitive regions at the Th2 locus
• Oct-1 mediates the association by binding these sites in cooperation with CTCF
• Defect in the association leads to enhanced IL-17 induction
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Figure 1. An interchromosomal association between the Th2 locus and the IL-17 locus in naïve T
cells
(A) 3-D DNA FISH of naïve T cells for the IFN-γ locus (red), the Th2 cytokine locus
(yellow) and the IL-17 locus (green). (B), (C) Cumulative frequency plots of normalized
distances between the indicated loci in naïve T cells [N=200 for (B) and N=100 for (C)]. (D)
Percentage of naïve T cells showing an interchromosomal distance equal to or below 1.5μm.
(E) Cumulative frequency plots of normalized distances between the Th2 and IL-17
cytokine loci in naïve, Th2 and Th17 cells (N=200). (F) Percentage of cells with a Th2/
IL-17 interchromosomal distance equal to or below 1.5μm. Data are representative of at least
three independent experiments and represented as mean +/− SEM. The KS-test was
performed and a P-value < 0.01 for (B) and a P-value < 0.001 for (C) and (E) was obtained.
See also Figure S1.
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Figure 2. RHS6 is a critical region that mediates interchromosomal associations of the Th2 and
IL-17 loci in naïve T cells
(A) Frequency of 3C PCR chimeric products obtained with one primer annealing to a region
of the Th2 locus (RHS2, RHS6 or RHS7) and the other primer annealing to a region of the
IL-17 locus (CNS87, CNS64, the IL-17A promoter, CNS164, the IL-17F exon or the IL-17F
promoter). For normalization, BAC DNA containing the Th2 locus or the IL-17 locus was
digested, ligated and used as a 3C PCR template. (B) Frequency 3C PCR chimeric products
between RHS6 and the IL-17A promoter or CNS164 in naïve T cells, Th2 cells, Th17 cells
and MEFs. (C) Frequency 3C PCR chimeric products between RHS7 and the IL-17A
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promoter or CNS164 in naïve T cells, Th2 cells, Th17 cells and MEFs. (D) Cumulative
frequency plots of normalized distances between the Th2 locus and the IL-17 locus (left) or
the IFN-γ locus and Th2 locus (right) in WT and RHS6 KO naïve T cells (N=200). (E)
Percentage of WT and RHS6 KO naïve T cells showing an interchromosomal separation
equal to or below 1.5μm. Data are representative of at least three independent experiments
and represented as mean +/− SEM. The KS-test was performed and P-value < 0.01 for (D)
was obtained. See also Figure S2.
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Figure 3. Oct-1 is bound at RHS6 and at the IL-17 promoter in naïve T cells
(A) ChIP-qPCR for Oct-1 on RHS6, the IL-17A promoter and the Taf12 promoter in naïve,
Th2 and Th17 cells. The results were averaged for three independent experiments. The
Student t-test was performed (**P < 0.01, ***P < 0.001). (B) Cumulative frequency plots of
normalized distances between the Th2 and IL-17 loci (left) or between the IFN-γ and Th2
loci (right) in RHS6ΔOct-1 WT and RHS6ΔOct-1 KO naïve T cells (N=200). (C)
Percentage of RHS6ΔOct-1 WT and RHS6ΔOct-1 KO naïve T cells showing an
interchromosomal separation equal to or below 1.5μm. (D) Cumulative frequency plots of
normalized distances between the Th2 and IL-17 loci (left) or between the IFN-γ and Th2
loci (right) in C57BL/6, IL-17A-GFP and IL-17A-GFP Oct-1 binding site mutant naïve T
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cells (N=100) (E) Percentage of C57BL/6, IL-17A-GFP and IL-17A-GFP Oct-1 binding site
mutant naïve T cells showing an interchromosomal separation equal to or below 1.5μm.
Data are representative of at least two independent experiments and represented as mean +/−
SEM. The KS-test was performed and P-value < 0.05 for (B) and (D) was obtained. See also
Figure S3.
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Figure 4. CTCF and cohesin bind to the Th2 locus and the IL-17 locus in T cells
ChIP-qPCR for control IgG, anti-CTCF and anti-Rad21 was performed using SYBR Green
and the designated primers within the Th2 locus (A) and the IL-17 locus (B). The location of
each binding site is indicated on the right of the graphs. The results were averaged for three
independent experiments and represented as mean +/− SEM. Statistical significance was
calculated using the Student t-test comparing naïve and effector T cells (*P < 0.05).
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Figure 5. The binding of Oct-1 and CTCF to their cognate sites is reduced in the absence of
either CTCF or RHS6 in naïve T cells
(A) ChIP-qPCR for Oct-1 on RHS6, the IL-17A promoter and the Taf12 promoter in
CTCFf/f CD4cre- and CTCFf/f CD4cre+ naïve T cells. (B) ChIP-qPCR for CTCF or Rad21
on the Th2 locus in WT and RHS6 KO naïve T cells. (C) ChIP-qPCR for CTCF on CBS5 of
the Th2 locus in RHS6ΔOct-1 WT and RHS6ΔOct-1 KO mice naïve T cells. (D) ChIP-
qPCR for CTCF or Rad21 on the IL-17 locus in WT and RHS6 KO naïve T cells. (E) ChIP-
qPCR for Oct-1 on the IL-17 promoter in WT and RHS6 KO mice naïve T cells. The results
were averaged for three independent experiments and represented as mean +/− SEM. The
Student t-test was performed (*P < 0.05, **P < 0.01, ***P < 0.001). (F) Co-
immunoprecipitation of Oct-1 with CTCF and vice versa. Intact or sonicated cell lysates
were incubated with control IgG, anti-CTCF or anti-Oct-1. Co-IP samples were subjected to
Western blotting with either anti-CTCF or anti-Oct-1 as indicated. See also Figure S4.
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Figure 6. The frequency of interchromosomal associations between the Th2 locus and the IL-17
locus is reduced in the absence of either Oct-1 or CTCF in naïve T cells
(A) Cumulative frequency plots of normalized distances between the Th2 and the IL-17 loci
(left panel), and between the IFN-γ and IL-17 loci (right panel) in Oct-1 WT and Oct-1 KO
recipient mice (N=100). (B) Percentage of naïve T cells from Oct-1 WT recipient and Oct-1
KO recipient mice showing an interchromosomal distance equal to or below 1.5μm. (C)
Frequency of 3C chimeric products between the Th2 locus (RHS6 or RHS7) and the IL-17
locus (the IL-17A promoter or CNS164) in naïve T cells from Oct-1 WT and Oct-1 KO
recipient mice. (D) Cumulative frequency plots of normalized distances between the Th2
and the IL-17 loci (left panel), and between the IFN-γ and the IL-17 loci (right panel) in
CTCFf/f CD4 cre+ and CTCFf/f CD4 cre- naïve T cells (N=100). (E) Percentage of CTCFf/f
CD4cre- and CTCFf/f CD4cre+ naïve T cells showing an interchromosomal distance equal
to or below 1.5μm. (F) Frequency 3C PCR chimeric products between the Th2 locus (RHS6
or RHS7) and the IL-17 locus (the IL-17A promoter or CNS164) in naïve T cells from
CTCFf/f CD4 cre+ and CTCFf/f CD4 cre- mice. Data are representative of at least three
independent experiments and represented as mean +/− SEM. The KS-test was performed for
each of the cumulative frequency plots. P-value < 0.001 for (A) and P-value < 0.05 for (D).
See also Figure S5.
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Figure 7. Analysis of IL-17 expression in RHS6 WT and KO T cells
(A) Quantitative PCR of IL-17 mRNA expression. Naïve T cells from WT and RHS6 KO
mice were treated with plate-bound anti-CD3, anti-CD28, TGF-β, IL-6 and IL-23 for the
indicated time. The Student t-test was performed (*P < 0.05. ***P < 0.001). (B) MACS
purified CD4+ cells from IL-17A-IRES-GFP reporter mice and RHS6 KO IL-17A-IRES-
GFP reporter mice were cultured in Th17 polarizing conditions for 2 days. The statistical
significance was calculated using the Student t-test (**P < 0.01). (C) Quantitative PCR for
RORγt mRNA expression at 24hrs of differentiation. Data are representative of at least three
independent experiments and represented as mean +/− SEM. The Student t-test was
performed. See also Figure S6.
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